Comparison of morbidity and absenteeism due to COVID-19 and seasonal influenza in a large cohort of health care personnel in the 2022 to 2023 season

Am J Infect Control. 2024 Nov;52(11):1248-1251. doi: 10.1016/j.ajic.2024.05.015. Epub 2024 May 29.

Abstract

Background: To compare the morbidity and work absenteeism associated with coronavirus disease 2019 (COVID-19) and influenza among health care personnel (HCP) in 2022 to 2023.

Methods: We followed 5,752 hospital-based HCP in Greece from November 14, 2022 through May 28, 2023. Symptomatic HCP was tested for SARS-CoV-2 and influenza by real-time polymerase chain reaction and/or rapid antigen detection test. The association between the duration of absenteeism and the type of disease was estimated by multivariable regression models.

Results: A total of 734 COVID-19 cases and 93 influenza cases were studied. The mean duration of absence per COVID-19 case was 5.8days compared with a mean of absence of 3.6days per influenza case (P value <.001). Overall, COVID-19 accounted for 4,245days missed during the study period compared with 333days missed due to influenza. Multivariable regression estimates indicated that HCP with COVID-19 had 1.91 more days of absenteeism (95% confidence interval 1.67-2.15) compared with those with influenza, on average.

Conclusions: As SARS-CoV-2 becomes endemic, COVID-19 remains the prevalent cause of morbidity and absenteeism among HCP, accounting for considerably more workdays missed compared with influenza. HCP should be up-to-date with COVID-19 booster vaccinations and annual influenza vaccination in order to protect them as well as health care systems from HCP absenteeism.

Keywords: Omicron subvariant; Vaccination.

Publication types

  • Comparative Study

MeSH terms

  • Absenteeism*
  • Adult
  • COVID-19* / epidemiology
  • Cohort Studies
  • Female
  • Greece / epidemiology
  • Health Personnel* / statistics & numerical data
  • Humans
  • Influenza, Human* / epidemiology
  • Influenza, Human* / prevention & control
  • Male
  • Middle Aged
  • Morbidity
  • SARS-CoV-2*
  • Seasons